TORONTO, June 12, 2018 /CNW/ - Eyecarrot Innovations
Corp ("Eyecarrot" or the "Company") (TSX-V: EYC) (OTCQB: EYCCF) is
pleased to announce the appointment of Dr. Stefan Collier as an Advisor in Neurophotonics;
a field of study focusing on the use of photons or quantum units of
light to study the brain and its processes at the cellular and
molecular level. Dr. Collier is one of the leading minds in his
field, having completed research in the subject going back 25
years. His previous work with the Binovi Touch Saccadic Fixator and
other Wayne Engineering Products dates back over 30 years and sets
the stage for exciting future developments with Eyecarrot. Dr.
Collier has worked with professional sports for many decades,
including world class athletes at the international Tennis level
and Formula 1 racing teams.
(Logo:
https://mma.prnewswire.com/media/688290/Eyecarrot_Logo.jpg
)
"We are very excited to continue to expand the Eyecarrot team
with the appointment of Dr. Collier. He has been recognized
internationally for his contribution to the field of Functional
Syntonic Optometry, speaks 7 languages, and will help the company
in expanding the Binovi Platform globally, including Europe" commented Adam
Cegielski, Eyecarrot CEO.
"I would like to commend the company on the recently released
Binovi Touch Saccadic Fixator, the expansion of the Binovi Platform
into Spain, and look forward to
working with the Eyecarrot team" stated Dr. Stefan Collier, Eyecarrot Advisor.
About Dr. Stefan Collier,
F.O., FCSO, CSO trustee, Dean BOAF
Dr. Stefan Collier is a leader in
bringing functional optometry & Syntonics to Europe. He received from OEPF the
Skeffington-Alexander International Award in 2010 and the
Armand Bastien Award in 2002 and
2004. He received from (CSO) College of Syntonic Optometry the H.
Riley Spitler Award in 2011. He
received from (SOE) European Society of Optometrists the SOE Award
in 2009.
Additional Awards:
- 2012 The Lifetime Achievement Award from Behavioral Optometry
Academy Foundation BOAF
- 2014 The International Lifetime Achievement Award from
OEPF
- 2015 The - Premio Robert y Linda
Sanet- Award from SIODEC
- 2016 The Advancement of Neuro-Optometric Rehabilitation Award
from NORA
About Eyecarrot
Eyecarrot's BinoviTM platform is an innovative healthcare
technology solution that integrates software, hardware, data and
expert knowledge. Binovi helps Optometrists treat vision issues
with in-office therapy as well as doctor led home based activities
to better serve and increase the patient's experience and their
therapy needs. The goal is to help transform vision performance for
the 1 in 4 people worldwide that suffer from vision-related issues
going beyond visual acuity. The company is transforming how vision
healthcare services are integrated, while addressing key challenges
in the health system.
On behalf of the Board of Directors
Adam Cegielski
President | CEO
Forward looking information
Certain statements contained in this news release constitute
"forward-looking information" as such term is used in applicable
Canadian securities laws. Forward-looking information is based on
plans, expectations, and estimates of management at the date the
information is provided and is subject to certain factors and
assumptions, including, that the Company's financial condition and
development plans do not change as a result of unforeseen events
and that the Company obtains regulatory approval. Forward-looking
information is subject to a variety of risks and uncertainties and
other factors that could cause plans, estimates and actual results
to vary materially from those projected in such forward-looking
information. Factors that could cause the forward-looking
information in this news release to change or to be inaccurate
include, but are not limited to, the risk that any of the
assumptions referred to prove not to be valid or reliable, that
occurrences such as those referred to above are realized and result
in delays, or cessation in planned work, that the Company's
financial condition and development plans change, and delays in
regulatory approval, as well as the other risks and uncertainties
applicable to the Company as set forth in the Company's continuous
disclosure filings filed under the Company's profile at
http://www.sedar.com . The Company undertakes no obligation to
update these forward-looking statements, other than as required by
applicable law.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Eyecarrot Innovations Corp